Impact of Non-Steroidal Anti-Inflammatory Drugs on Recurrence and Survival after Melanoma Surgery: A Cohort Study

References

• Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472–492. doi:10.3322/caac.21409.
   PubMed Web of Science ®Google Scholar
• Stav I, Gyawali B, Goldstein DA. Duration of adjuvant immunotherapy-biologic, clinical and economic considerations. Med Oncol. 2018;35(12):160. doi:10.1007/s12032-018-1218-0.
   PubMed Web of Science ®Google Scholar
• de Melo AC, Wainstein AJA, Buzaid AC, Thuler L. Melanoma signature in Brazil: epidemiology, incidence, mortality, and trend lessons from a continental mixed population country in the past 15 years. Melanoma Res. 2018;28(6):629–636. doi:10.1097/CMR.0000000000000511.
   PubMed Web of Science ®Google Scholar
• Wall T, Sherwin A, Ma D, Buggy DJ. Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review. Br J Anaesth. 2019;123(2):135–150. doi:10.1016/j.bja.2019.04.062.
   PubMed Web of Science ®Google Scholar
• Hiller JG, Perry NJ, Poulogiannis G, Riedel B, Sloan EK. Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol. 2018;15(4):205–218. doi:10.1038/nrclinonc.2017.194.
   PubMed Web of Science ®Google Scholar
• Kofler L, Breuninger H, Häfner HM, Schweinzer K, Schnabl SM, Eigentler TK, Leiter U. Lymph node dissection for melanoma using tumescence local anaesthesia: an observational study. Eur J Dermatol. 2018;28(2):177–185. doi:10.1684/ejd.2018.3250.
   PubMed Web of Science ®Google Scholar
• Schlagenhauff B, Ellwanger U, Breuninger H, Stroebel W, Rassner G, Garbe C. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res. 2000;10:165–169.
   PubMed Web of Science ®Google Scholar
• Ben-David B. Anaesthesia in cancer surgery: can it affect cancer survival? Curr Clin Pharmacol. 2016;11(1):4–20. doi:10.2174/1574884711666160122093154.
   PubMed Web of Science ®Google Scholar
• Baxevanis CN, Reclos GJ, Gritzapis AD, Dedousis GV, Missitzis I, Papamichail M. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer. 1993;72(2):491–501. doi:10.1002/1097-0142(19930715)72:2<491::AID-CNCR2820720227>3.0.CO;2-1.
   PubMed Web of Science ®Google Scholar
• Walker W, Rotondo D. Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis. Immunology. 2004;111(3):298–305. doi:10.1111/j.1365-2567.2004.01810.x.
   PubMed Web of Science ®Google Scholar
• Specht C, Bexten S, Kolsch E, Pauels HG. Prostaglandins, but not tumor-derived IL-10, shut down concomitant tumor-specific CTL responses during murine plasmacytoma progression. Int J Cancer. 2001;91(5):705–712. doi:10.1002/1097-0215(200002)9999:9999<::AID-IJC1066>3.0.CO;2-J.
   PubMed Web of Science ®Google Scholar
• Hoang KG, Allison S, Murray M, Petrovic N. Prostanoids regulate angiogenesis acting primarily on IP and EP4 receptors. Microvasc Res. 2015;101:127–134. doi:10.1016/j.mvr.2015.07.004.
   PubMed Web of Science ®Google Scholar
• Mohn CE, Fernandez-Solari J, De Laurentiis A, Prestifilippo JP, de la Cal C, Funk R, et al. The rapid release of corticosterone from the adrenal induced by ACTH is mediated by nitric oxide acting by prostaglandin E2. Proc Natl Acad Sci USA. 2005;102(17):6213–6218. doi:10.1073/pnas.0502136102.
   PubMed Web of Science ®Google Scholar
• Forget P, Machiels JP, Coulie PG, Mohn CE, Fernandez-Solari J, De Laurentiis A, et al. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. Ann Surg Oncol. 2013;20:650–660. doi:10.1245/s10434-013-3136-x.
   Web of Science ®Google Scholar
• Yeh CC, Lin JT, Jeng LB, Ho HJ, Yang HR, Wu MS, et al. Nonsteroidal anti-inflammatory drugs are associated with reduced risk of early hepatocellular carcinoma recurrence after curative liver resection: a nationwide cohort study. Ann Surg. 2015;261(3):521–526. doi:10.1097/SLA.0000000000000746.
   PubMed Web of Science ®Google Scholar
• Shaashua L, Shabat-Simon M, Haldar R, Matzner P, Zmora O, Shabtai M, et al. Perioperative COX-2 and β-adrenergic blockade improves metastatic biomarkers in breast cancer patients in a phase-II randomized trial. Clin Cancer Res. 2017;23(16):4651–4661. doi:10.1158/1078-0432.CCR-17-0152.
   PubMed Web of Science ®Google Scholar
• Jiang W, Wang L, Zhang J, Shen H, Dong W, Zhang T, et al. Effects of postoperative non-steroidal anti-inflammatory drugs on long-term survival and recurrence of patients with non-small cell lung cancer. Medicine. 2018;97(39):e12442. doi:10.1097/MD.0000000000012442.
   PubMed Web of Science ®Google Scholar
• Lee DY, Lim JH, Kim YJ, Kim SD, Park S-W, Kwon SK, et al. Effect of celecoxib on survival of mobile tongue cancer. Anticancer Res. 2015;35(7):4235–4241.
   PubMed Web of Science ®Google Scholar
• Cata JP, Guerra CE, Chang GJ, Gottumukkala V, Joshi GP. Non-steroidal anti-inflammatory drugs in the oncological surgical population: beneficial or harmful? A systematic review of the literature. Br J Anaesth. 2017;119(4):750–764. doi:10.1093/bja/aex225.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi:10.1016/S0140-6736(07)61602-X.
   PubMed Web of Science ®Google Scholar
• Bagaria SP, Faries MB, Morton DL. Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute. J Surg Oncol. 2010;101(8):669–676. doi:10.1002/jso.21581.
   PubMed Web of Science ®Google Scholar
• Amin MB, Edge SB, Greene FL. American Joint Committee on Cancer. AJCC cancer staging manual. 8th ed. Chicago (IL): Springer; 2017.
   Google Scholar
• Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, et al. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). Ann Oncol. 2015;26(5):873–879. doi:10.1093/annonc/mdv106.
   PubMed Web of Science ®Google Scholar
• Buggy DJ, Freeman J, Johnson MZ, Leslie K, Riedel B, Sessler DI, et al. Systematic review and consensus definitions for standardised endpoints in perioperative medicine: postoperative cancer outcomes. Br J Anaesth. 2018;121(1):38–44. doi:10.1016/j.bja.2018.03.020.
   PubMed Web of Science ®Google Scholar
• Kramar A, Negrier S, Sylvester R, Joniau S, Mulders P, Powles T, et al. Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project. Ann Oncol. 2015;26(12):2392–2398. doi:10.1093/annonc/mdv380.
   PubMed Web of Science ®Google Scholar
• Bellera CA, Penel N, Ouali M, Bonvalot S, Casali PG, Nielsen OS, et al. Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). Ann Oncol. 2015;26(5):865–872. doi:10.1093/annonc/mdu360.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2019.
   Google Scholar
• Schoenfeld D. Chi-squared goodness-of-fit tests for the proportional hazards regression model. Biometrika. 1980;67(1):145–153. doi:10.1093/biomet/67.1.145.
   Web of Science ®Google Scholar
• Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983;39(2):499–503. doi:10.2307/2531021.
   PubMed Web of Science ®Google Scholar
• Nilsen OG. Clinical pharmacokinetics of tenoxicam. Clin Pharmacokinet. 1994;26(1):16–43. doi:10.2165/00003088-199426010-00003.
   PubMed Web of Science ®Google Scholar
• STARSurg Collaborative. Safety of nonsteroidal anti-inflammatory drugs in major gastrointestinal surgery: a prospective, multicenter cohort study. World J Surg. 2017;41:47–55. doi:10.1007/s00268-016-3727-3.
   PubMed Web of Science ®Google Scholar
• Fewell Z, Davey Smith G, Sterne JA. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol. 2007;166(6):646–655. doi:10.1093/aje/kwm165.
   PubMed Web of Science ®Google Scholar
• Forget P, Bouche G, Duhoux FP, Coulie PG, Decloedt J, Dekleermaker A, et al. Intraoperative ketorolac in high-risk breast cancer patients. a prospective, randomized, placebo-controlled clinical trial. PLoS One. 2019;14(12):e0225748. doi:10.1371/journal.pone.0225748.
   PubMed Web of Science ®Google Scholar
• Hudson LG, Cook LS, Grimes MM, Muller CY, Adams SF, Wandinger-Ness A. Dual actions of ketorolac in metastatic ovarian cancer. Cancers. 2019;11:e1049. doi:10.3390/cancers11081049.
   PubMed Web of Science ®Google Scholar
• Jasiecka A, Maślanka T, Jaroszewski JJ. Pharmacological characteristics of metamizole. Pol J Vet Sci. 2014;17(1):207–214. doi:10.2478/pjvs-2014-0030.
   PubMed Web of Science ®Google Scholar
• Brune K. Prostaglandins and the mode of action of antipyretic analgesic drugs. Am J Med. 1983;75(5A):19–23. doi:10.1016/0002-9343(83)90228-0.
   PubMed Web of Science ®Google Scholar
• Singh PP, Lemanu DP, Taylor MHG, Hill AG. Association between preoperative glucocorticoids and long-term survival and cancer recurrence after colectomy: follow-up analysis of a previous randomized controlled trial. Br J Anaesth. 2014;113:i68–i73. doi:10.1093/bja/aet577.
   PubMed Web of Science ®Google Scholar
• Retsky M, Rogers R, Demicheli R, Hrushesky WJ, Gukas I, Vaidya JS, et al. NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Res Treat. 2012;134(2):881–888. doi:10.1007/s10549-012-2094-5.
   PubMed Web of Science ®Google Scholar
• Moiniche S, Kehlet H, Dahl JB. A qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief: the role of timing of analgesia. Anesthesiology. 2002;96:725–741.
   PubMed Web of Science ®Google Scholar